View in EDS

Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes.

Saved in:
Bibliographic Details
Title: Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes.
Authors: Böttcher M; Clinical Pharmacology, Bayer AG, Wuppertal, Germany., Düngen HD; Department of Internal Medicine, Cardiology, Charité-Universitaetsmedizin Berlin, Berlin, Germany., Corcea V; Department of Cardiac Surgery, PMSI Clinical Republican Hospital 'T. Mosneaga', Chisinau, Republic of Moldova., Donath F; SocraTec R&D GmbH, Erfurt, Germany., Fuhr R; Early Phase Clinical Unit, Parexel, Berlin, Germany., Gal P; Centre for Human Drug Research, Leiden, The Netherlands.; Clinical Pharmacology and Toxicology Department, Leiden University Medical Center, Leiden, The Netherlands., Mikus G; Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital Heidelberg, Heidelberg, Germany., Trenk D; Department University Heart Center Campus Bad Krozingen, Clinics of Cardiology and Angiology-Clinical Pharmacology, University Medical Center Freiburg, Freiburg, Germany., Coenen M; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany., Pires PV; Research and Development, Bayer AG, Wuppertal, Germany., Maschke C; Study Management, Bayer AG, Wuppertal, Germany., Aliprantis AO; Translational Medicine, Merck & Co., Inc., Rahway, New Jersey, USA.; Pioneering Medicines, Flagship Pioneering, Boston, Massachusetts, USA., Besche N; Chrestos Concept GmbH & Co. KG, Essen, Germany., Becker C; Clinical Pharmacology, Bayer AG, Wuppertal, Germany. corina.becker@bayer.com.
Source: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2023 Mar; Vol. 23 (2), pp. 145-155. Date of Electronic Publication: 2023 Jan 12.
Publication Type: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase I; Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36633816
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Böttcher+M%22">Böttcher M</searchLink>; Clinical Pharmacology, Bayer AG, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Düngen+HD%22">Düngen HD</searchLink>; Department of Internal Medicine, Cardiology, Charité-Universitaetsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Corcea+V%22">Corcea V</searchLink>; Department of Cardiac Surgery, PMSI Clinical Republican Hospital 'T. Mosneaga', Chisinau, Republic of Moldova.<br /><searchLink fieldCode="AU" term="%22Donath+F%22">Donath F</searchLink>; SocraTec R&D GmbH, Erfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Fuhr+R%22">Fuhr R</searchLink>; Early Phase Clinical Unit, Parexel, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Gal+P%22">Gal P</searchLink>; Centre for Human Drug Research, Leiden, The Netherlands.; Clinical Pharmacology and Toxicology Department, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mikus+G%22">Mikus G</searchLink>; Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Trenk+D%22">Trenk D</searchLink>; Department University Heart Center Campus Bad Krozingen, Clinics of Cardiology and Angiology-Clinical Pharmacology, University Medical Center Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Coenen+M%22">Coenen M</searchLink>; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Pires+PV%22">Pires PV</searchLink>; Research and Development, Bayer AG, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Maschke+C%22">Maschke C</searchLink>; Study Management, Bayer AG, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Aliprantis+AO%22">Aliprantis AO</searchLink>; Translational Medicine, Merck & Co., Inc., Rahway, New Jersey, USA.; Pioneering Medicines, Flagship Pioneering, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Besche+N%22">Besche N</searchLink>; Chrestos Concept GmbH & Co. KG, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Becker+C%22">Becker C</searchLink>; Clinical Pharmacology, Bayer AG, Wuppertal, Germany. corina.becker@bayer.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967755%22">American journal of cardiovascular drugs : drugs, devices, and other interventions</searchLink> [Am J Cardiovasc Drugs] 2023 Mar; Vol. 23 (2), pp. 145-155. <i>Date of Electronic Publication: </i>2023 Jan 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase I; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>100967755 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-187X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211753277%22">11753277 </searchLink><i>NLM ISO Abbreviation: </i>Am J Cardiovasc Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36633816
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40256-022-00557-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 145
    Titles:
      – TitleFull: Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Böttcher M
      – PersonEntity:
          Name:
            NameFull: Düngen HD
      – PersonEntity:
          Name:
            NameFull: Corcea V
      – PersonEntity:
          Name:
            NameFull: Donath F
      – PersonEntity:
          Name:
            NameFull: Fuhr R
      – PersonEntity:
          Name:
            NameFull: Gal P
      – PersonEntity:
          Name:
            NameFull: Mikus G
      – PersonEntity:
          Name:
            NameFull: Trenk D
      – PersonEntity:
          Name:
            NameFull: Coenen M
      – PersonEntity:
          Name:
            NameFull: Pires PV
      – PersonEntity:
          Name:
            NameFull: Maschke C
      – PersonEntity:
          Name:
            NameFull: Aliprantis AO
      – PersonEntity:
          Name:
            NameFull: Besche N
      – PersonEntity:
          Name:
            NameFull: Becker C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2023 Mar
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1179-187X
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: American journal of cardiovascular drugs : drugs, devices, and other interventions
              Type: main
ResultId 1